Field of the Invention
The present invention relates to porous implants and, in particular, to an implant with a porous material mounted on a core.
Description of the Related Art
Dental implants are commonly used to anchor dental restorations or prosthetic teeth at one or more edentulous sites in a patient's dentition at which the patient's original teeth have been lost or damaged. The dental implant is typically threaded or press-fit into a bore which is drilled into the patient's mandible or maxilla at the edentulous site. Typically, a dental implant device is provided in one or two pieces. For a two piece device, an anchoring member or implant supports a separate coronal dental abutment, which in turn provides an interface between the implant and a dental restoration. For a one piece integral device, the device has an abutment section coronal to an implant section of the device. In either case, the restoration is typically a porcelain crown fashioned according to known methods.
For a two-piece device, there are two-stage surgery implants (also called endosseous implants) that only rise to the crest of the mandible or maxilla. In this case, the surgery is often performed in two stages. In the initial stage, an incision is made in the patient's gingiva at an edentulous side, and a bore is drilled into the patient's mandible or maxilla at the edentulous site, followed by threading or impacting a dental implant into the bore using a suitable driver. Thereafter, a cap is fitted onto the implant to close the abutment coupling structure of the implant, and the gingiva is sutured over the implant. Over a period of several months, the patient's jaw bone grows around the implant to securely anchor the implant in the surrounding bone, a process known as osseointegration.
In a second stage of the procedure following osseointegration, the dentist reopens the gingiva at the implant site and secures an abutment and optionally, a temporary prosthesis or temporary healing member, to the implant. Then, a suitable permanent prosthesis or crown is fashioned, such as from one or more impressions taken of the abutment and the surrounding gingival tissue and dentition. The temporary prosthesis or healing member is removed and replaced with the permanent prosthesis, which is attached to the abutment with cement or with a fastener, for example.
Alternatively, a one-stage surgery, two-piece implant, also called a transgingival implant, is placed in a single stage because it extends through the gingiva for attachment to an abutment. The one-piece implant also is placed in the jaw in a single stage.
Although the osseointegration of existing dental implants into surrounding bone has proven adequate, further improvements in osseointegration of dental implants are desired. For example, patients would prefer the shortest healing time from surgery to the time the implant can be fully impacted by occlusal forces. Also, a desire exists to provide strongly osseointegrated implants for high risk patients, such as smokers, diabetics and/or abnormally slow bone growth.
Referring to
Now in more detail, in the illustrated example, the implant 10 is a dental implant for insertion into a mandible or maxilla. The implant 10 is used to anchor one or more dental prostheses, and includes a coronal head portion or head 20. The interior portion or core 16 extends apically from the head 20. In one form, the head 20 and core 16 are integrally formed but may be separate pieces secured to each other by threading, friction fit, welding (laser or e-beam), and so forth. A separate anchor 22 (also referred to as the stem or apical portion) is configured to engage the core 16 so that the head 20 and the anchor 22 cooperatively retain the porous exterior portion 14 therebetween on the implant 10.
For the illustrated example, the coronal end 24 of the head 20 is configured with male or female engagement structure that receives corresponding structure from a separate abutment. It will be appreciated, however, that instead of the two-stage implant 10 shown, the head 20 may have an extended height to extend through gingiva and form a single-stage implant, or may have an integral abutment to form a one-piece implant.
The head 20 has an outer cylindrical or tapering surface 26 that extends to an apical end surface 28. The core 16 has a reduced outer diameter compared to the diameter of the outer surface 26 and extends apically from an apical end surface 28 of head 20 so that apical end surface 28 forms a shoulder to abut and retain exterior portion 12 on the core 16. In one specific form, the exterior portion 12 is a sleeve or collar with a bore 30 that receives the core 16. In one form, the collar 12 has a radial thickness of about 0.03 inches (about 0.75 mm). A coronal end 32 of the exterior portion 12 faces and/or abuts the apical end surface 28. An apical end 34 of the exterior portion 12 faces and/or engages the anchor 22.
The anchor 22 may be secured to an apical end portion 56 of the core 16 to secure the exterior portion 12 between the head 20 and the anchor 22. The anchor 22 may have a bore 36 for receiving the core 16, and the two pieces may then be welded together thereby permanently securing the exterior portion 12 on the core 16. It will be understood that many alternative configurations are contemplated such as the core 16 and anchor 22 being held together by threads or press-fit, or the core 16 being integral to the anchor 22 or entirely separate instead of integral to the head 20 as mentioned above, and as long as the porous exterior portion 12 is maintained adjacent the core 16.
The core 16, head 20, and anchor 22 (whether or not one or more of the pieces are separate or integrally formed) are made of a suitable biocompatible material such as titanium, titanium alloy, stainless steel, zirconium, cobalt-chromium molybdenum alloy, polymers such as polyether ketone ketone (PEKK) for one example, ceramic, and/or composite material.
The outer surfaces 26 and 37 of the head 20 and anchor 22 may have threads 38 for threading the implant 10 into a bore in bone or may be press-fit into the bore instead. Thus, the outer surfaces 26 and 37 may alternatively or additionally have surface treatment for promoting cortical bone and/or cancellous bone growth. The head outer surface 26 may additionally or alternatively be treated to promote an epithelium or soft tissue barrier and/or promote soft tissue growth if the head 20 extends into the gingival layer. In this case, barrier or soft tissue growth treatments can be placed adjacent to soft tissue or the interface between bone and soft tissue. Such treatments may include macro or micro threading, or circumferential or annular grooves, other patterned or random recesses caused by etching (such as acid etching), blasting (such as with sand, with or without HA particles, for example), or also coating of titania (titanium oxide) or other materials that create some adhesion between soft tissues and biomaterials. The surface treatment of outer surfaces 26 and 37 may or may not be the same as the surface treatment of the core 16 described below.
Referring to
As shown in
The porous tantalum may include up to 75%-85% or more of voids therein. Thus, porous tantalum is a lightweight, strong porous structure which is substantially uniform and consistent in composition, and closely resembles the structure of natural cancellous bone, thereby providing a matrix into which cancellous bone may grow to anchor implant 10 into the surrounding bone of a patient's jaw which increases stability. The rough exterior surface of such porous metal part 12 has a relatively high friction coefficient with adjacent bone forming the bore that receives the implant 10 to further increase initial stability as alluded to above. This structure can produce superior aesthetic results by restricting movement of the implant. These implants can be placed without supplementary surgical procedures, such as bone grafting, and can be placed in areas where traditional implants have been less successful, such as with reduced or decayed alveolar sections, or with patients that have abnormally slow or reduced bone growth.
More specifically, the high level of friction between the porous material and the bone provides immediate stability post surgery. The tantalum struts that extend from the surface of the material create a rasping action that may stimulate bone growth and anchor the implant at the time of placement. The extremely biocompatible tantalum metal that the porous material is made from allows bone to directly oppose the material. The tantalum forms a porous scaffolding that allows bone to grow into the material providing a rapid osseointegration response that quickly augments the initial mechanical fixation to secure the implant. The implant with in-grown bone may have stability greater than a comparably sized implant with only on-grown bone. Finally, the composite of in-grown bone and such a porous material has elastic properties much closer to bone than a solid metal implant, creating a loading environment that is conducive to maintaining bone near the implant.
Regarding the initial stability, as an implant with the porous material is inserted into the bore or cavity in bone, the porous material will bite into the bone by grating, chipping and/or flaking bone pieces off of the bone sidewalls against which the implant device is being placed. When the implant is inserted into the bore or cavity, this “rasping” action may form slight recesses or indents within the sidewall. This may restrict rotational or twisting motion of the implant device within the bore or cavity since the implant device does not have the clearance to rotate out of the indents and within the bore.
The rasping action also accelerates osseointegration onto the implant device and into the pores of the porous material due to the bone compaction into the pores. First, the grating of the bone structure causes the bone to bleed which stimulates bone growth by instigating production of beneficial cells such as osteoblasts and osteoclasts. Second, the bone pieces that fall into the pores on the porous material assist with bone remodeling. In the process of bone remodeling, osteoblast cells use the bone pieces as scaffolding and create new bone material around the bone pieces. Meanwhile osteoclast cells remove the bone pieces through resorption by breaking down bone and releasing minerals, such as calcium, from the bone pieces and back into the blood stream. The osteoblast cells will continue to replace the grated bone pieces from the pores and around the implant device with new and healthy bone within and surrounding the extraction site. Thus, the porous material has increased resistance to twisting or rotation, allows for immediate or very early loading, and increases long-term stability due to the improved osseointegration. Such an implant with ingrown bone has stability greater than a comparably sized implant with only on-grown bone. For instance, loads that typically require a 16 mm long implant may be adequately impacted by an 8 mm long implant. These advantages may be realized no matter the form of the porous implant.
Porous tantalum structure 40 may be made in a variety of densities in order to selectively tailor the structure for particular applications. In particular, the porous tantalum may be fabricated to virtually any desired porosity and pore size, whether uniform or varying, and can thus be matched with the surrounding natural bone in order to provide an improved matrix for bone in-growth and mineralization. This includes a gradation of pore size on a single implant such that pores are larger on an apical end to match cancellous bone, and smaller on a coronal end to match cortical bone, or even to receive soft tissue ingrowth. Also, the porous tantalum could be made denser with fewer pores in areas of high mechanical stress. Instead of smaller pores in the tantalum, this can also be accomplished by filling all, or some of the pores with a solid material.
To provide additional initial mechanical strength and stability to the porous structure, the porous structure may be infiltrated with a filler material such as a non-resorbable polymer or a resorbable polymer. Examples of non-resorbable polymers for infiltration of the porous structure may include a polyaryl ether ketone (PAEK) such as polyether ketone ketone (PEKK), polyether ether ketone (PEEK), polyether ketone ether ketone ketone (PEKEKK), polymethylacrylate (PMMA), polyetherimide, polysulfone, and polyphenolsulfone.
Examples of resorbable polymers may include polylactic co-glycolic acid (PLGA), polylactic acid (PLA), polyglycolic acid (PGA), polyhydroxybutyrate (PHB), and polyhydroxyvalerate (PHV), and copolymers thereof, polycaprolactone, polyanhydrides, and polyorthoesters. By providing additional initial mechanical strength and stability with a resorbable filler material, a titanium reinforcing implant core may not be required through the entire length of the porous material. The resorbable material would resorb as the bone grows in and replaces it, which maintains the strength and stability of the implant.
Referring again to
The treated area 54 is covered by the exterior portion 12 so that the treated area 54 is accessible for direct contact with bone that grows generally radially through the exterior portion 12. In one form, the treated area 54 aligns or corresponds to the exterior portion 12 such that the treated area 54 only extends underneath the exterior portion 12 and does not extend beyond the exterior portion 12 where it is uncovered. In this case, the surface area and outer periphery of the treated area 54 are the same or about the same as that of the exterior portion 12. By another approach, the treated area 54 may be disposed on locations on the core 16 that is not directly covered by the exterior portion 12. For example, the treated area 54 may cover the entire core 16 while the exterior portion 12 only extends in a coronal-apical direction over a part of the core 16. Otherwise, the treated area 54 may have a smaller surface area than that of the exterior portion 12 so that it only extends under the exterior portion 12 whether or not the periphery of the treated area 54 is the same shape as the outer periphery of the exterior portion 12. At a minimum, treated area 54 has at least some part extending underneath the exterior portion 12 and accessible from the exterior surface 50 of the implant 10 through the passages 44.
It will be appreciated that instead of a sleeve or collar, the exterior portion 12 may only form part of the circumference of the implant 10, or may only be located on one or more sides of the implant 10. In that case, the treated area 54 of the core 16 may or may not be configured to align only with the area covered by the exterior portion 12.
In one form, the treated area 54 is at least roughened. This may be performed by gritblasting or sandblasting the treated area 54 to create a random pattern of pits on the outer surface 52 of the core 16 with an average roughness (Ra) of about 20 to 50 μm. The blasting may be performed by spraying Hydroxyapatite (HA) or other bio-compatible materials. By one approach, the treated area 54 has only been treated with sandblasting but alternatively could have a variety of different treatments instead of, or in addition to, the sandblasting. This includes acid etching of the treated area 54 to create random or patterned roughening.
In another example of a treatment 18, the treated area 54 may have at least one coating of a bio-compatible material. The coating may include a bio-reactive material such as HA, collagen, peptides, or other growth factors to promote bone growth onto the core 16 (and/or promote soft tissue growth if the core extends through gingiva). The coating could alternatively or additionally be anti-bacterial and include transition metal ions such as Ag, Cu, or Zn, other bactericidel polymers, antibiotics and/or nanoscale roughness to prevent bacterial colonization on the treated area 54. Other coatings may be applied to form a porosity into the coating for better attachment. This may include Cancellous Structure Titanium (CSTi) provided by Zimmer, Inc. that includes Titanium powder sintered to the core 16 which forms pores through the coating and a roughness to provide improved fixation to the bone or soft tissue. The treated area 54 may alternatively, or additionally, have other roughening treatments such as a circumferentially oriented roughness like threads or annular grooves, or other patterns of roughness (whether on a macro, micro, or nano scale) as long as it intentionally relates to direct attachment to bone (or soft tissue when the core extends near or into the gingiva).
Typically an implant is treated with sandblasting and so forth after the implant is fully assembled so that treatment to exposed areas of an implant can take place in a single step. In this case, however, since the outer surface 52 of the core 16 is treated and then covered, the pieces of implant 10 are treated separately before assembly. Thus, first the head 20 with the core 16, the porous exterior portion 12, and the anchor 22 are shaped as described above. The head 20 and, in turn, the core 16 are then sandblasted or otherwise treated as described above for direct engagement with bone or soft tissue. The head 20 and core 16 are treated separately from the anchor 22, before the exterior portion 12 is mounted on the core 16, and before the head 20 is attached to the anchor 22.
In one form, the entire head 20 including the apical end portion 56 of the core 16 are blasted. It will be appreciated, however, that the core 16 could be the only area treated or blasted while the rest of the head 20 is masked from the treatment. This may be desired if the other exposed areas of the implant 10 receive a different type of treatment that could be damaged by the treatment performed at the core 16, such as coatings, blasting with different particles or particles of different sizes, patterned etching, and so forth. Also, the sidewall 57 of the apical end portion 56 could be masked since it is unexposed within anchor 22 when the implant 10 is assembled, or to provide a smooth connection surface if needed.
Once the treated area 54 is complete, the exterior porous portion 12 is mounted on the core 16, and then the anchor 22 is mounted to the core 16 and secured thereon by laser welding, threading, or other permanent connection. In the illustrated form, after the apical end portion 56 of the core 16 is placed in the bore 36 on the anchor 22, the two are laser welded together along a seam 58 at the apical end portion 60 of the anchor 22. When the head 20 and anchor 22 are laser welded together, the welding process may also undesirably smooth the roughening treatment on the anchor 22 such that sandblasting may need to be reapplied to the anchor 22 on the areas affected by the welding.
In another aspect of implant 10, the core 16 is shaped to limit rotation between the head 20 and the exterior portion 12. If the exterior portion 12 is able to rotate relative to the core 16 and head 20 while the implant 10 is being inserted into a bore in bone, the exterior portion 12 may undesirably bind with the bone (while the head 20 still rotates) so that the implant 10 cannot be properly inserted all the way into the bone bore. Also, better osseointegration occurs when the position of the porous exterior portion 12 in the mouth is not able to change significantly (by rotating on the implant for example) when impacted by occlusal forces thereby maintaining initially fragile bone growth through the exterior portion 12. This results in more long term and short term stability for the implant 10. To accomplish these goals, an anti-rotational connection is formed between the exterior portion 12 and the core 16.
In detail, the implant 10 generally defines a longitudinal axis L while the periphery 19 of the core 16 extends on a cross-section perpendicular to axis L, and the exterior portion 12 has a generally cylindrical wall 62 that defines the bore 30 of the exterior portion 12 and extends around axis L.
The outer surface 52 of the core 16 has at least one generally longitudinally extending groove or flute 68. In the illustrated form, the outer surface 52 forms a circumferential array of the flutes 68 around the core 16. Thus, the flutes 68 form the sides on the periphery 19 providing the periphery 19 with a generally polygonal shape with relatively sharp corners or edges 64 that cut into the wall 62 of the exterior portion 12 when the exterior portion 12 is being inserted axially onto the core 16. The edges 64 are formed relatively sharp by forming each flute 68 with a concave curved surface 66 with a radius r. Thus, in one form, the core 16 has at least two adjoining concave surfaces 66 so that the junction of the two adjoining surfaces 66 form the peak or edge 64 for engaging the collar. This generally secures the edges 64 within the wall 62 of the exterior portion 12 to rotationally secure the collar 12 relative to the core 16.
The radius r of the concave surface 66 is set sufficiently small so that the core 16 retains sufficient mass to have strength to adequately absorb occlusal forces. The radius r is also sufficiently large to provide the peaks 64 with a sharp edge to provide a strong, non-rotational connection between the core 16 and collar 12. In one form, the periphery 19 varies between six and twelve concave sides 66 with a diameter d (from edge to edge) of about 0.060 to 0.230 inches and a radius r from about 0.031 to 0.250 inches depending on the desired size of the implant. In the illustrated form, the eight sides 66 of core 16 have a radius of about 0.0625 inches and an edge to edge diameter of about 0.120 inches. The inner diameter of wall 62 is about 0.114 inches so that each edge 64 cuts into the wall 62 at least about 0.003 inches. Manufacturing tolerances may result in a cut depth of between about 0.002 inches and 0.006 inches. In one form, the edges 64 should cut into the wall 62 at least about 0.002 inches to form a strong anti-rotational engagement.
It will be appreciated that while radius r is the same for all of the sides 66 to maintain a generally uniform cutting depth into the porous exterior portion 12, radius r may be varied as desired instead. This may cause edges that extend farther radially and cut deeper into wall 62 only at certain points around the circumference of the periphery 19 such as two or four opposite sides of the core 16 for a relatively stronger hold.
In an alternative form, the periphery 19 may be other non-circular shapes while the wall 62 remains circular. This creates sections of the core 16 with varying radii that do not have the clearance to rotate relative to the exterior portion 12 and vice-versa. In this case, the periphery 19 may be a flat-sided polygon (whether regular or non-regular) or generally ovaline (such as elliptical, oval, obround, and so forth) or may be some other combination of curved and flat sides. In another alternative, the wall 62 and the periphery 19 have different non-circular shapes to better reduce rotation between the core 16 and the wall 62 such as by having an oval periphery and a hexagonal wall in cross-section as one example. In these cases, an initial rotation of the wall 62 against the periphery 19 fixes the wall 62 against the core 16 by friction or by a portion of the core 16 cutting into the wall 62.
In yet another alternative form, the implant may have the opposite configuration where the outer surface 52 of the core 16 is cylindrical while the wall 62 of the exterior portion 12 is non-circular to form a friction fit between the two.
In a further alternative form, the periphery 19 may have a non-circular shape that corresponds to a non-circular shape of the wall 62 to limit rotation between the two components. For example, the periphery 19 or core 16 may have an outer surface 52 with at least one flat side or portion that coincides with and engages a flat portion of the wall 62 to resist rotation. In one form, both the core 16 and wall 62 may have aligned polygonal cross-sections.
It should also be noted that while the implant 10 may have a generally cylindrical outer surface 50, the implant 10 may also have a morse-type taper so that its diameter decreases as it extends apically to further increase friction with surrounding bone when the implant 10 is pressed or threaded into a bore in the bone. The outer periphery of the implant 10 may also have a non-cylindrical shape to create more friction with a circular bore in the bone.
Referring to
Referring to
Referring to
By another approach, the treatment areas mentioned herein are zones, and each implant may have a number of zones where each zone has a treatment selected to accomplish a different purpose. In one form, there are at least two distinct zones along the longitudinal axis of the implant, whether the zones are adjacent or spaced from each other. In one case, one or more zones may be placed within bone and its treatment is selected for bone growth, while other zone or zones extend within soft tissue and their treatment is selected for soft tissue growth (or to establish a barrier as mentioned above). The zones in bone may be particularly selected to grow cortical or cancelleous bone. In one form, the implant 10 may have a number of axially spaced partial or full rings for bone growth for example. In the illustrated example, implant 200 may also have one or more zones 214 for soft tissue growth and one or more porous or treated zones 216 (shown in dashed line on
It will also be understood that the combination of a porous exterior portion intentionally covering a treated area of an interior portion may be used on endosseous implants other than dental implants including implants along the length of a bone, or an implant at joints such as for knees, hips, shoulders, elbows, the spine, and so forth.
While this invention has been described as having a preferred design, the present invention can be further modified within the spirit and scope of this disclosure. This application is therefore intended to cover any variations, uses, or adaptations of the invention using its general principles. Further, this application is intended to cover such departures from the present disclosure as come within known or customary practice in the art to which this invention pertains and which fall within the limits of the appended claims.
Number | Name | Date | Kind |
---|---|---|---|
2721387 | Ashuckian | Oct 1955 | A |
3314420 | Smith et al. | Apr 1967 | A |
3423830 | Halpern et al. | Jan 1968 | A |
3423831 | Semmelman | Jan 1969 | A |
3435526 | Brancato | Feb 1969 | A |
3497953 | Weissman | Mar 1970 | A |
3685115 | Scott | Aug 1972 | A |
3713860 | Auskern | Jan 1973 | A |
3740851 | Weissman | Jun 1973 | A |
3797113 | Brainin | Mar 1974 | A |
3849887 | Brainin | Nov 1974 | A |
3896547 | Kulwiec | Apr 1975 | A |
3905109 | Cohen et al. | Jun 1975 | A |
3896457 | Yamanishi et al. | Jul 1975 | A |
3906550 | Rostoker et al. | Sep 1975 | A |
3919773 | Freeman | Nov 1975 | A |
3934347 | Lash et al. | Jan 1976 | A |
3992725 | Homsy | Nov 1976 | A |
4011602 | Rybicki et al. | Mar 1977 | A |
4016651 | Kawahara et al. | Apr 1977 | A |
4086701 | Kawahara et al. | May 1978 | A |
4097935 | Jarcho | Jul 1978 | A |
4122605 | Hirabayashi et al. | Oct 1978 | A |
4131597 | Bluethgen et al. | Dec 1978 | A |
4178686 | Riess et al. | Dec 1979 | A |
4195366 | Jarcho et al. | Apr 1980 | A |
4199864 | Ashman | Apr 1980 | A |
4229170 | Perez | Oct 1980 | A |
4244689 | Ashman | Jan 1981 | A |
4252525 | Child | Feb 1981 | A |
4259072 | Hirabayashi | Mar 1981 | A |
4281991 | Michi et al. | Aug 1981 | A |
4321042 | Scheicher | Mar 1982 | A |
4375967 | Schaefer | Mar 1983 | A |
4379694 | Reiss | Apr 1983 | A |
4381918 | Ehrnford | May 1983 | A |
4411624 | Ogino et al. | Oct 1983 | A |
4431420 | Adair | Feb 1984 | A |
4439152 | Small | Mar 1984 | A |
4448758 | Nagai et al. | May 1984 | A |
4475892 | Faunce | Oct 1984 | A |
4478904 | Ducheyne et al. | Oct 1984 | A |
4483678 | Nishio et al. | Nov 1984 | A |
4492577 | Farris et al. | Jan 1985 | A |
4531915 | Tatum, Jr. | Jul 1985 | A |
4531916 | Scantelbury et al. | Jul 1985 | A |
4536158 | Bruins et al. | Aug 1985 | A |
4548959 | Nagai et al. | Oct 1985 | A |
4556534 | Burnett et al. | Dec 1985 | A |
4708652 | Fujiu et al. | Nov 1987 | A |
4713006 | Hakamatsuka et al. | Dec 1987 | A |
4722688 | Lonca | Feb 1988 | A |
4731085 | Koch | Mar 1988 | A |
4737411 | Graves et al. | Apr 1988 | A |
4743260 | Burton | May 1988 | A |
4744757 | Adair et al. | May 1988 | A |
4744759 | Bowen | May 1988 | A |
4820157 | Salvo | Apr 1989 | A |
4842517 | Kawahara et al. | Jun 1989 | A |
4871384 | Kasuga | Oct 1989 | A |
4872839 | Branjnovic | Oct 1989 | A |
4872840 | Bori | Oct 1989 | A |
4877400 | Holsclaw | Oct 1989 | A |
4880610 | Constantz | Nov 1989 | A |
4906190 | Michna | Mar 1990 | A |
4909738 | Ai et al. | Mar 1990 | A |
4957554 | Mathers et al. | Sep 1990 | A |
4957819 | Kawahara et al. | Sep 1990 | A |
4960733 | Kasuga et al. | Oct 1990 | A |
4969817 | Hiranuma et al. | Nov 1990 | A |
4969913 | Ojima | Nov 1990 | A |
4983182 | Kijima et al. | Jan 1991 | A |
5000685 | Brajnovic | Mar 1991 | A |
5002488 | Homsy | Mar 1991 | A |
5004421 | Lazarof | Apr 1991 | A |
5007835 | Valen | Apr 1991 | A |
5009709 | Ibsen et al. | Apr 1991 | A |
5049074 | Otani | Sep 1991 | A |
5055497 | Okada et al. | Oct 1991 | A |
5061285 | Koch | Oct 1991 | A |
5062798 | Tsuge et al. | Nov 1991 | A |
5064731 | Miyazaki et al. | Nov 1991 | A |
5076789 | Tanaka | Dec 1991 | A |
5087200 | Branjovic et al. | Feb 1992 | A |
5120340 | Ducheyne et al. | Jun 1992 | A |
5123844 | Wakai et al. | Jun 1992 | A |
5125839 | Ingber et al. | Jun 1992 | A |
5125971 | Nonami et al. | Jun 1992 | A |
5139424 | Yli-Urpo | Aug 1992 | A |
5152687 | Amino | Oct 1992 | A |
5176747 | Panzera et al. | Jan 1993 | A |
5180303 | Hornburg et al. | Jan 1993 | A |
5186626 | Tanaka | Feb 1993 | A |
5192325 | Kijima et al. | Mar 1993 | A |
5194000 | Dury | Mar 1993 | A |
5194001 | Salvo | Mar 1993 | A |
5199873 | Schulte et al. | Apr 1993 | A |
5205745 | Kamiya et al. | Apr 1993 | A |
5232365 | Ikehara | Aug 1993 | A |
5232878 | Kasuga et al. | Aug 1993 | A |
5236458 | Ducheyne et al. | Aug 1993 | A |
5238405 | Marlin | Aug 1993 | A |
5254005 | Zuest | Oct 1993 | A |
5282861 | Kaplan | Feb 1994 | A |
5282863 | Burton | Feb 1994 | A |
5288232 | Panzera et al. | Feb 1994 | A |
5306673 | Hermansson et al. | Apr 1994 | A |
5308391 | Komma et al. | May 1994 | A |
5310343 | Hasegawa et al. | May 1994 | A |
5312254 | Rosenlicht | May 1994 | A |
5314334 | Panzera et al. | May 1994 | A |
5316476 | Krauser | May 1994 | A |
5342201 | Oden | Aug 1994 | A |
5344318 | Wilson et al. | Sep 1994 | A |
5344457 | Pilliar et al. | Sep 1994 | A |
5346397 | Braiman | Sep 1994 | A |
5415546 | Cox, Sr. | May 1995 | A |
5419702 | Beaty et al. | May 1995 | A |
5425639 | Anders | Jun 1995 | A |
5425640 | Scharf | Jun 1995 | A |
5439380 | Marlin | Aug 1995 | A |
5443515 | Cohen et al. | Aug 1995 | A |
5449291 | Lueschen et al. | Sep 1995 | A |
5458488 | Chalifoux | Oct 1995 | A |
5468544 | Marcolongo et al. | Nov 1995 | A |
5470230 | Daftary et al. | Nov 1995 | A |
5476383 | Beaty et al. | Dec 1995 | A |
5549123 | Okuyama et al. | Aug 1996 | A |
5554665 | Tateosian et al. | Sep 1996 | A |
5562733 | Weissbach et al. | Oct 1996 | A |
5571016 | Ingber et al. | Nov 1996 | A |
5572652 | Robusto et al. | Nov 1996 | A |
5575652 | Gaffar et al. | Nov 1996 | A |
5584693 | Nishihara | Dec 1996 | A |
5591030 | Thiel et al. | Jan 1997 | A |
5612049 | Li et al. | Mar 1997 | A |
5614330 | Panzera et al. | Mar 1997 | A |
5621035 | Lyles et al. | Apr 1997 | A |
5624262 | Yarovesky et al. | Apr 1997 | A |
5645934 | Marcolongo et al. | Jul 1997 | A |
5674069 | Osorio | Oct 1997 | A |
5676745 | Kelly et al. | Oct 1997 | A |
5683249 | Ibsen et al. | Nov 1997 | A |
5685714 | Beaty et al. | Nov 1997 | A |
5695337 | Tyszblat Sadoun | Dec 1997 | A |
5697785 | Delahaye | Dec 1997 | A |
5697976 | Chesterfield et al. | Dec 1997 | A |
5697997 | Aronsson et al. | Dec 1997 | A |
5698019 | Frank et al. | Dec 1997 | A |
5713994 | Kramer et al. | Feb 1998 | A |
5723007 | Engel et al. | Mar 1998 | A |
5727943 | Beaty et al. | Mar 1998 | A |
5755809 | Cohen et al. | May 1998 | A |
5759036 | Hinds | Jun 1998 | A |
5762500 | Lazarof | Jun 1998 | A |
5772438 | Deom | Jun 1998 | A |
5775912 | Panzera et al. | Jul 1998 | A |
5785524 | Wolf | Jul 1998 | A |
5833464 | Foser | Oct 1998 | A |
5833463 | Hurson | Nov 1998 | A |
5839900 | Billet et al. | Nov 1998 | A |
5843348 | Giordano | Dec 1998 | A |
5849068 | Hofmann et al. | Dec 1998 | A |
5873721 | Willoughby | Feb 1999 | A |
5910273 | Thiel et al. | Jun 1999 | A |
5915967 | Clokie | Jun 1999 | A |
5925180 | Frank et al. | Jul 1999 | A |
5931674 | Hanosh et al. | Aug 1999 | A |
5934906 | Phimmasone | Aug 1999 | A |
5939211 | Mormann | Aug 1999 | A |
5947732 | Beaty et al. | Sep 1999 | A |
5947737 | Billet et al. | Sep 1999 | A |
5947893 | Agrawal et al. | Sep 1999 | A |
5951290 | Ardizio et al. | Sep 1999 | A |
5951293 | Billet et al. | Sep 1999 | A |
5951295 | Lyles et al. | Sep 1999 | A |
5961328 | Somborac et al. | Oct 1999 | A |
5964592 | Hites et al. | Oct 1999 | A |
5971760 | Letcher | Oct 1999 | A |
5975905 | Kim et al. | Nov 1999 | A |
5984683 | Sakata et al. | Nov 1999 | A |
5989026 | Rogers et al. | Nov 1999 | A |
5989027 | Wagner et al. | Nov 1999 | A |
6010337 | Billet et al. | Jan 2000 | A |
6012923 | Bassett et al. | Jan 2000 | A |
6013591 | Ying et al. | Jan 2000 | A |
6027742 | Lee et al. | Feb 2000 | A |
6039568 | Hinds | Mar 2000 | A |
6045361 | Misch et al. | Apr 2000 | A |
6048203 | Rosenberg | Apr 2000 | A |
6048205 | Wright | Apr 2000 | A |
6054400 | Brink et al. | Apr 2000 | A |
RE36689 | Beaty et al. | May 2000 | E |
6056547 | Names | May 2000 | A |
6063442 | Cohen et al. | May 2000 | A |
6080692 | Reise et al. | Jun 2000 | A |
6087553 | Cohen et al. | Jul 2000 | A |
6095817 | Wagner et al. | Aug 2000 | A |
6117456 | Lee et al. | Sep 2000 | A |
6120293 | Lazzara et al. | Sep 2000 | A |
6126445 | Willoughby | Oct 2000 | A |
6126732 | Hofmann et al. | Oct 2000 | A |
6135775 | Weisman | Oct 2000 | A |
6146423 | Cohen et al. | Nov 2000 | A |
6152737 | Beaty et al. | Nov 2000 | A |
6159010 | Rogers et al. | Dec 2000 | A |
6159417 | Giordano | Dec 2000 | A |
6168435 | Beaty et al. | Jan 2001 | B1 |
6168436 | O'Brien | Jan 2001 | B1 |
6168633 | Shoher et al. | Jan 2001 | B1 |
6183256 | Fisher et al. | Feb 2001 | B1 |
6183515 | Barlow et al. | Feb 2001 | B1 |
6186791 | Karmaker et al. | Feb 2001 | B1 |
6193516 | Story | Feb 2001 | B1 |
6200137 | Holand et al. | Mar 2001 | B1 |
6206192 | Winstead et al. | Mar 2001 | B1 |
6213775 | Reipur | Apr 2001 | B1 |
6214049 | Gayer et al. | Apr 2001 | B1 |
6214368 | Lee et al. | Apr 2001 | B1 |
6224662 | Nemeth | May 2001 | B1 |
6244869 | Billet et al. | Jun 2001 | B1 |
6250922 | Bassett et al. | Jun 2001 | B1 |
6267597 | Kim | Jul 2001 | B1 |
6270347 | Webster et al. | Aug 2001 | B1 |
6271282 | Giordano | Aug 2001 | B1 |
6280863 | Frank et al. | Aug 2001 | B1 |
6283753 | Willoughby | Sep 2001 | B1 |
6287341 | Lee et al. | Sep 2001 | B1 |
6299448 | Zdrahala et al. | Oct 2001 | B1 |
6306784 | Drescher et al. | Oct 2001 | B1 |
6322728 | Brodkin et al. | Nov 2001 | B1 |
6325628 | Morgan | Dec 2001 | B1 |
6331312 | Lee et al. | Dec 2001 | B1 |
6342458 | Schweiger et al. | Jan 2002 | B1 |
6343930 | Beaty et al. | Feb 2002 | B1 |
6345984 | Karmaker et al. | Feb 2002 | B2 |
6354836 | Panzera et al. | Mar 2002 | B1 |
6362250 | Karmaker et al. | Mar 2002 | B1 |
6362251 | Alkemper et al. | Mar 2002 | B1 |
6379153 | Schroering | Apr 2002 | B1 |
6386876 | Lee | May 2002 | B1 |
6394806 | Kumar | May 2002 | B1 |
6402517 | Hozumi et al. | Jun 2002 | B1 |
6419491 | Ricci et al. | Jul 2002 | B1 |
6431868 | Story | Aug 2002 | B2 |
6439890 | Karmaker et al. | Aug 2002 | B1 |
6447549 | Taft | Sep 2002 | B1 |
6450813 | McDonald et al. | Sep 2002 | B1 |
6451292 | Warford, III et al. | Sep 2002 | B2 |
6454569 | Hollander et al. | Sep 2002 | B1 |
6485849 | Petticrew | Nov 2002 | B2 |
6495073 | Bodenmiller et al. | Dec 2002 | B2 |
6497573 | Wagner et al. | Dec 2002 | B2 |
6503625 | Rieder et al. | Jan 2003 | B1 |
6514453 | Vigliotti et al. | Feb 2003 | B2 |
6527553 | Yeung | Mar 2003 | B2 |
6540784 | Barlow et al. | Apr 2003 | B2 |
6627327 | Reidt et al. | Sep 2003 | B2 |
6641775 | Vigliotti et al. | Nov 2003 | B2 |
6648645 | MacDougald et al. | Nov 2003 | B1 |
6666684 | Names | Dec 2003 | B1 |
6669476 | Prestipino et al. | Dec 2003 | B2 |
6679701 | Blacklock | Jan 2004 | B1 |
6689202 | Panzera | Feb 2004 | B2 |
6743936 | Wellinhoff et al. | Jun 2004 | B1 |
6752863 | Lyles et al. | Jun 2004 | B2 |
6755651 | Brodbeck | Jun 2004 | B2 |
6787584 | Jia et al. | Sep 2004 | B2 |
6797006 | Hodorek | Sep 2004 | B2 |
6808659 | Schulman et al. | Oct 2004 | B2 |
6821462 | Schulman et al. | Nov 2004 | B2 |
6846181 | Karmaker et al. | Jan 2005 | B2 |
6878456 | Castro et al. | Apr 2005 | B2 |
6881488 | Giordano | Apr 2005 | B2 |
6916177 | Lin et al. | Jul 2005 | B2 |
6932606 | Aravena et al. | Aug 2005 | B2 |
6945448 | Medlin et al. | Sep 2005 | B2 |
6949251 | Dalal et al. | Sep 2005 | B2 |
6953594 | Lee et al. | Oct 2005 | B2 |
6976999 | Charlebois et al. | Dec 2005 | B2 |
6984261 | Cummings et al. | Jan 2006 | B2 |
6986660 | Kumar et al. | Jan 2006 | B2 |
6994726 | Lin et al. | Feb 2006 | B2 |
7011522 | Panzera et al. | Mar 2006 | B2 |
7291012 | Lyren | Nov 2007 | B2 |
8562348 | Collins et al. | Oct 2013 | B2 |
8602782 | Lomicka | Dec 2013 | B2 |
8899982 | Damstra et al. | Dec 2014 | B2 |
9066771 | Collins et al. | Jun 2015 | B2 |
9439738 | Lomicka | Sep 2016 | B2 |
20010000486 | Story | Apr 2001 | A1 |
20010051832 | Bakker et al. | Dec 2001 | A1 |
20020028424 | Prestipino et al. | Mar 2002 | A1 |
20020039718 | Kwan | Apr 2002 | A1 |
20020076673 | Wagner et al. | Jun 2002 | A1 |
20020115742 | Trieu et al. | Aug 2002 | A1 |
20020155412 | Panzera et al. | Oct 2002 | A1 |
20020160334 | Brodbeck | Oct 2002 | A1 |
20030031984 | Rusin et al. | Feb 2003 | A1 |
20030068598 | Vallittu et al. | Apr 2003 | A1 |
20030073394 | Reidt et al. | Apr 2003 | A1 |
20030087984 | Erbe et al. | May 2003 | A1 |
20030096214 | Luthardt et al. | May 2003 | A1 |
20030113690 | Hollander et al. | Jun 2003 | A1 |
20030134925 | Guzauskas | Jul 2003 | A1 |
20030148247 | Sicurelli, Jr. et al. | Aug 2003 | A1 |
20040024081 | Trieu et al. | Feb 2004 | A1 |
20040058299 | Molin et al. | Mar 2004 | A1 |
20040064192 | Bubb | Apr 2004 | A1 |
20040097627 | Vallittu et al. | May 2004 | A1 |
20040106085 | Vallittu et al. | Jun 2004 | A1 |
20040106087 | Weigl et al. | Jun 2004 | A1 |
20040131562 | Gower et al. | Jul 2004 | A1 |
20040152034 | Cummings et al. | Aug 2004 | A1 |
20040170946 | Lyren | Sep 2004 | A1 |
20040197737 | Uckelmann et al. | Oct 2004 | A1 |
20040234925 | Benhamou | Nov 2004 | A1 |
20040241614 | Goldberg et al. | Dec 2004 | A1 |
20050014108 | Wohrle et al. | Jan 2005 | A1 |
20050023710 | Brodkin et al. | Feb 2005 | A1 |
20050028424 | Poinski | Feb 2005 | A1 |
20050031704 | Ahn | Feb 2005 | A1 |
20050084533 | Howdle et al. | Apr 2005 | A1 |
20050084819 | Sims et al. | Apr 2005 | A1 |
20050084821 | Sims et al. | Apr 2005 | A1 |
20050096652 | Burton | May 2005 | A1 |
20050100724 | Seargeant | May 2005 | A1 |
20050109060 | Cummings et al. | May 2005 | A1 |
20050123672 | Justin et al. | Jun 2005 | A1 |
20050136378 | Ennajimi | Jun 2005 | A1 |
20050184134 | Charlebois et al. | Aug 2005 | A1 |
20050191248 | Hunter et al. | Sep 2005 | A1 |
20050221259 | Anderson | Oct 2005 | A1 |
20050261795 | Ghosh et al. | Nov 2005 | A1 |
20050266382 | Soler et al. | Dec 2005 | A1 |
20060075826 | Roberts et al. | Apr 2006 | A1 |
20060107292 | Moon | May 2006 | A1 |
20070015110 | Zhang et al. | Jan 2007 | A1 |
20070111165 | Wallick et al. | May 2007 | A1 |
20070118221 | Robie et al. | May 2007 | A1 |
20070148621 | Yakir | Jun 2007 | A1 |
20070184265 | Ranganathan et al. | Aug 2007 | A1 |
20080050699 | Zhang et al. | Feb 2008 | A1 |
20080241793 | Collins et al. | Oct 2008 | A1 |
20090011384 | Collins et al. | Jan 2009 | A1 |
20090036908 | Zokol et al. | Feb 2009 | A1 |
20090061387 | Lomicka et al. | Mar 2009 | A1 |
20090061388 | Collins et al. | Mar 2009 | A1 |
20090061389 | Lomicka et al. | Mar 2009 | A1 |
20090098510 | Zhang | Apr 2009 | A1 |
20090098511 | Zhang | Apr 2009 | A1 |
20090233256 | Schroering | Sep 2009 | A1 |
20100003638 | Collins et al. | Jan 2010 | A1 |
20100003639 | Salvi et al. | Jan 2010 | A1 |
20100003640 | Damstra et al. | Jan 2010 | A1 |
20100114314 | Lomicka et al. | May 2010 | A1 |
20140017633 | Lomicka | Jan 2014 | A1 |
Number | Date | Country |
---|---|---|
2506845 | Jul 2004 | CA |
101505678 | Aug 2009 | CN |
102596095 | Jul 2012 | CN |
4209569 | Nov 1994 | DE |
19529036 | Mar 1997 | DE |
10105398 | Aug 2002 | DE |
0950421 | Oct 1999 | EA |
0345584 | Dec 1980 | EP |
0266313 | May 1988 | EP |
0271236 | Jun 1988 | EP |
0345581 | Dec 1989 | EP |
0366018 | May 1990 | EP |
0417018 | Mar 1991 | EP |
0333503 | Feb 1993 | EP |
0366018 | May 1993 | EP |
0417018 | May 1994 | EP |
0498923 | May 1995 | EP |
0467948 | Jan 1996 | EP |
0560279 | Jun 2000 | EP |
0806211 | Oct 2002 | EP |
1281372 | Feb 2003 | EP |
1712205 | Oct 2006 | EP |
1598028 | Dec 2007 | EP |
2796265 | Jan 2001 | FR |
1526780 | Sep 1978 | GB |
2401867 | Nov 2004 | GB |
2401867 | Oct 2005 | GB |
2416996 | Feb 2006 | GB |
61275205 | Dec 1986 | JP |
61275205 | Dec 1986 | JP |
63290559 | Nov 1988 | JP |
63290559 | Nov 1988 | JP |
1025480 | Jan 1989 | JP |
1025840 | Jan 1989 | JP |
1025849 | Jan 1989 | JP |
2002126071 | May 2002 | JP |
WO-8900410 | Jan 1989 | WO |
WO-9011979 | Oct 1990 | WO |
WO-9320773 | Oct 1993 | WO |
WO-9421190 | Sep 1994 | WO |
WO-9528973 | Nov 1995 | WO |
WO-9721393 | Jun 1997 | WO |
WO-9741809 | Nov 1997 | WO |
WO-9830170 | Jul 1998 | WO |
WO-0021455 | Apr 2000 | WO |
WO-0132072 | May 2001 | WO |
WO-0107193 | Nov 2001 | WO |
WO-0187193 | Nov 2001 | WO |
WO-0234155 | May 2002 | WO |
WO-0236039 | May 2002 | WO |
WO-02062901 | Aug 2002 | WO |
WO-02064100 | Aug 2002 | WO |
WO-03065939 | Aug 2003 | WO |
WO-03065996 | Aug 2003 | WO |
WO-03078508 | Sep 2003 | WO |
WO-03094774 | Nov 2003 | WO |
WO-04054464 | Jul 2004 | WO |
WO-2006107292 | Oct 2006 | WO |
WO 2007027794 | Mar 2007 | WO |
WO-2010002663 | Jan 2010 | WO |
WO-2010106241 | Sep 2010 | WO |
Entry |
---|
“U.S. Appl. No. 12/624,608, Examiner Interview Summary dated Jan. 15, 2013”, 3 pgs. |
“U.S. Appl. No. 12/624,608, Final Office Action dated Oct. 25, 2011”, 12 pgs. |
“U.S. Appl. No. 12/624,608, Non Final Office Action dated May 9, 2011”, 12 pgs. |
“U.S. Appl. No. 12/624,608, Non Final Office Action dated Nov. 19, 2012”, 14 pgs. |
“U.S. Appl. No. 12/624,608, Notice of Allowance dated Jun. 4, 2013”, 10 pgs. |
“U.S. Appl. No. 12/624,608, Response filed Jan. 25, 2012 to Final Office Action dated Oct. 25, 2011”, 16 pgs. |
“U.S. Appl. No. 12/624,608, Response filed Apr. 19, 2013 to Non Final Office Action dated Nov. 19, 2012”, 17 pgs. |
“U.S. Appl. No. 12/624,608, Response filed Apr. 25, 2011 to Restriction Requirement dated Apr. 8, 2011”, 2 pgs. |
“U.S. Appl. No. 12/624,608, Response filed Aug. 9, 2011 to Non Final Office Action dated May 9, 2011”, 14 pgs. |
“U.S. Appl. No. 12/624,608, Restriction Requirement dated Apr. 8, 2011”, 8 pgs. |
“U.S. Appl. No. 14/031,608, Advisory Action dated Nov. 25, 2015”, 3 pgs. |
“U.S. Appl. No. 14/031,608, Final Office Action dated Sep. 17, 2015”, 12 pgs. |
“U.S. Appl. No. 14/031,608, Non Final Office Action dated Jan. 13, 2016”, 25 pgs. |
“U.S. Appl. No. 14/031,608, Non Final Office Action dated Apr. 2, 2015”, 13 pgs. |
“U.S. Appl. No. 14/031,608, Notice of Allowance dated Apr. 29, 2016”, 5 pgs. |
“U.S. Appl. No. 14/031,608, Preliminary Amendment dated Nov. 15, 2013”, 7 pgs. |
“U.S. Appl. No. 14/031,608, Response filed Mar. 31, 2016 to Non-Final Office Action dated Jan. 13, 2016”, 8 pgs. |
“U.S. Appl. No. 14/031,608, Response filed Jun. 23, 2015 to Non Final Office Action dated Apr. 2, 2015”, 13 pgs. |
“U.S. Appl. No. 14/031,608, Response filed Nov. 10, 2015 to Final Office Action dated Sep. 17, 2015”, 12 pgs. |
“Canadian Application Serial No. 2,773,224, Office Action dated Oct. 21, 2015”, 3 pgs. |
“Chinese Application Serial No. 201080050015.9, Office Action dated Jul. 2, 2014”, w/English Translation, 19 pgs. |
“Chinese Application Serial No. 201080050015.9, Response filed Nov. 17, 2014 to Office Action dated Jul. 2, 2014”, w/English Claims, 12 pgs. |
“Flocculants, Binders, and Bonds”, Chapter 11, Molecular Binders, (1995), 173-177. |
“International Application Serial No. PCT/US2006/020130, International Search Report dated Feb. 6, 2007”, 7 pgs. |
“International Application Serial No. PCT/US2006/033893, International Search Report dated Jan. 29, 2007”, 1 pg. |
“International Application Serial No. PCT/US2007/069562, International Search Report dated Jul. 7, 2008”, 4 pgs. |
“International Application Serial No. PCT/US2008/074616, International Search Report dated Dec. 16, 2008”, 4 pgs. |
“International Application Serial No. PCT/US2008/074642, International Search Report dated Feb. 12, 2009”, 4 pgs. |
“International Application Serial No. PCT/US2008/074645, International Search Report dated Dec. 29, 2008”, 9 pgs. |
“International Application Serial No. PCT/US2008/074655, International Search Report dated Feb. 18, 2009”, 9 pgs. |
“International Application Serial No. PCT/US2009/048456, International Search Report dated Apr. 27, 2010”, 5 pgs. |
“International Application Serial No. PCT/US2009/048469, International Search Report and Written Opinion dated Oct. 19, 2009”, 9 pgs. |
“International Application Serial No. PCT/US2009/048476, International Search Report dated Dec. 10, 2009”, 13 pgs. |
“International Application Serial No. PCT/US2009/048481, International Search Report dated Dec. 10, 2009”, 13 pgs. |
“International Application Serial No. PCT/US2009/062308, International Search Report dated Jan. 21, 2010”, 9 pgs. |
“International Application Serial No. PCT/US2010/055975, International Preliminary Report on Patentability dated May 30, 2012”, 7 pgs. |
“International Application Serial No. PCT/US2010/055975, International Search Report dated Mar. 17, 2011”, 4 pgs. |
“International Application Serial No. PCT/US2010/055975, Written Opinion dated Mar. 17, 2011”, 6 pgs. |
“Japanese Application Serial No. 2012-539941, Notice of Reasons for Rejection dated Jun. 2, 2015”, English Translation, 4 pgs. |
“Japanese Application Serial No. 2012-539941, Office Action dated Apr. 30, 2014”, w/English Translation, 10 pgs. |
“Japanese Application Serial No. 2012-539941, Response filed Oct. 23, 2014”, w/English Claims, 12 pgs. |
“PEEK-CLASSIX”, Information Sheet Invibio Ltd., Properties of PEEK-CLASSIX White Granular, (Nov. 2003), 2 pgs. |
“Two Applications of Transmucosal Milled Ceramic in Implantology”, Preliminary Clinical Examples; Implant Quintessence International vol. 27, Issue 8, (1996), 533-548. |
Barclay, C W, et al., “The clinical assessment of a ceramic-coated transmucosal dental implant collar”, International Journal of Prosthodont. 1996—vol. 9, Issue 5, [Online]. Retrieved from the internet <URL:http://www.ncbi.nlm.nih.gov/pubmed/9108748>, (Oct. 1996), 466-472. |
Cass, Richard B, et al., “Innovative Ceramic-Fiber Technology Energizes Advanced Cerametrics”, The American Ceramic Society, American Ceramic Society Bulletin, (Nov. 2003), 9701-9706. |
Ganz, Scott D, “Presurgical Planning With CT-Derived Fabrication of Surgical Guides”, J Oral Maxiofac Surg 63, Suppl 2, (2005), 59-73 pgs. |
Kan, Joseph Y K, “Computer-Guided Immediate Provisionalization of Anterior Multiple Adjacent Implants; Surgical and Prosthodontia: Rationale”, Practical Procedures & Aethetic Dentistry, vol. 18, No. 10, (2006), 617-623 pgs. |
Matinlinna, Jukka P, et al., “An Introduction to Silanes and Their Clinical Applications in Dentistry”, The International Journal of Prosthodontics, vol. 17, No. 2, (2004), 155-164. |
Reed, James S., “Chapter 24, Injection Molding”, Principles of Ceramics Processing, 2nd Edition, New York : Wiley, (1995), 477-481. |
Rosenfeld, Alan L, “Prosthetically Directed Implant Placement Using Computer Software to Ensure Precise Placement and Predictable Prosthetic Outcomes. Part 1: Diagnostics, Imaging, and Collaborative Accountability”, International Journal of Periodontics & Restorative Dentistry, vol. 26, No. 3, (2006), 215-221. |
Zhou, Yan, et al., “Shape Optimization of Randomly Oriented Short Fibers for Bone Cement Reinforcements”, Materials Science & Engineering A 393, (2005), 374-381. |
“Canadian Application Serial No. 2,773,224, Response filed Apr. 7, 2016 to Office Action dated Oct. 21, 2015”, 7 pgs. |
“Chinese Application Serial No. 201080050015.9, Office Action dated Dec. 11, 2014”, w/English Translation, 10 pgs. |
“Chinese Application Serial No. 201080050015.9, Response filed Feb. 25, 2015 to Office Action dated Dec. 11, 2014”, w/English Claims, 10 pgs. |
“Japanese Application Serial No. 2012-539941, Response filed Nov. 27, 2015 to Office Action dated Jun. 2, 2015”, w/English Claims, 11 pgs. |
Number | Date | Country | |
---|---|---|---|
20170049536 A1 | Feb 2017 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14031608 | Sep 2013 | US |
Child | 15259454 | US | |
Parent | 12624608 | Nov 2009 | US |
Child | 14031608 | US |